Literature DB >> 15853982

Risk of colorectal cancer in ulcerative colitis in India.

Subramanian Venkataraman1, Vivek Mohan, Balakrishnan S Ramakrishna, Shajan Peter, Ashok Chacko, George Chandy, George Kurian, Susy Kurian, Minnie Mathan, Vadakkenadayil I Mathan, Susama Patra, Anna Pulimood, David Dk Rolston.   

Abstract

BACKGROUND: The risk for colorectal cancer (CRC) in ulcerative colitis (UC) in India is not known.
METHOD: Retrospective cohort from a tertiary level hospital in South India. Analysis of archived records of all patients with UC who underwent colonoscopy and segmental biopsies over the last 25 years. Incidence densities and risk of developing high grade dysplasia or CRC was calculated and chi-squared test was performed for risk factors of interest.
RESULTS: Complete records were available for 532 patients, 336 (63.2%) male. The mean (+/- SEM) duration of illness was 6.04 +/- 0.29 years. In total, 234 patients (44%) had pancolitis, 121 (22.7%) had left-sided colitis and 177 (33.3%) had proctitis or proctosigmoiditis. Overall, five (0.94%) patients developed carcinoma and one (0.19%) patient had high grade dysplasia. The incidence density and risk of developing either CRC or high grade dysplasia was zero in the first 10 years of disease. In those with disease duration of 10-20 years, incidence density was 2.34 per 1000 person years' duration (PYD) for all patients with colitis and 4.5 per 1000 PYD for patients with pancolitis alone. This corresponded to risks of 2.3% and 4.4%, respectively. For those with disease duration longer than 20 years, incidence density was 2.73 per 1000 PYD for all patients and 4.9 per 1000 PYD for patients with pancolitis. This corresponded to risks of 5.8% and 10.2%, respectively. Duration of disease beyond 10 years and extent of colitis were the only risk factors significantly associated with CRC.
CONCLUSIONS: The risk of developing CRC is Indian patients with UC is lower than that reported from the West. Strategies for cancer surveillance in Indian patients with UC need to be tailored accordingly.

Entities:  

Mesh:

Year:  2005        PMID: 15853982     DOI: 10.1111/j.1440-1746.2005.03810.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  20 in total

1.  Risk of ulcerative colitis-associated colorectal cancer in China: a multi-center retrospective study.

Authors:  Wei Gong; Nonghua Lv; Bangmao Wang; Ye Chen; Yinglong Huang; Wenshen Pan; Bo Jiang
Journal:  Dig Dis Sci       Date:  2011-09-22       Impact factor: 3.199

2.  Colorectal cancers in ulcerative colitis from a low-prevalence area for colon cancer.

Authors:  Devendra Desai; Sudeep Shah; Abhijit Deshmukh; Philip Abraham; Anand Joshi; Tarun Gupta; Ramesh Deshpande; Varun Khandagale; Siji George
Journal:  World J Gastroenterol       Date:  2015-03-28       Impact factor: 5.742

Review 3.  Risk of colorectal cancer in Asian patients with ulcerative colitis: a systematic review and meta-analysis.

Authors:  Sawan Bopanna; Ashwin N Ananthakrishnan; Saurabh Kedia; Vijay Yajnik; Vineet Ahuja
Journal:  Lancet Gastroenterol Hepatol       Date:  2017-02-21

4.  A low-cost method for chromoendoscopy for surveillance in ulcerative colitis.

Authors:  Sawan Bopanna; Saurabh Kedia; Vineet Ahuja
Journal:  Indian J Gastroenterol       Date:  2016-11-23

Review 5.  Colorectal cancer surveillance in inflammatory bowel disease: A critical analysis.

Authors:  Devendra Desai; Nutan Desai
Journal:  World J Gastrointest Endosc       Date:  2014-11-16

6.  Long-term follow-up reveals high incidence of colorectal cancer in Indian patients with inflammatory bowel disease.

Authors:  Sawan Bopanna; Saurabh Kedia; Prasenjit Das; S Dattagupta; V Sreenivas; V Pratap Mouli; Rajan Dhingra; Rajesh Pradhan; N Suraj Kumar; Dawesh P Yadav; Govind Makharia; Vineet Ahuja
Journal:  United European Gastroenterol J       Date:  2016-11-17       Impact factor: 4.623

7.  Inflammatory bowel disease in India--changing paradigms.

Authors:  Gautam Ray
Journal:  Int J Colorectal Dis       Date:  2010-11-10       Impact factor: 2.571

8.  What can we learn from inflammatory bowel disease in developing countries?

Authors:  Sunny H Wong; Siew C Ng
Journal:  Curr Gastroenterol Rep       Date:  2013-03

9.  Survey of inflammatory bowel diseases in India.

Authors:  Govind K Makharia; Balakrishnan S Ramakrishna; Philip Abraham; Gourdas Choudhuri; Sri Prakash Misra; Vineet Ahuja; Shobna J Bhatia; Deepak K Bhasin; Sunil Dadhich; Gopal K Dhali; Devendra C Desai; Uday C Ghoshal; B D Goswami; Sanjeev K Issar; Ajay K Jain; Venkataraman Jayanthi; Goundappa Loganathan; C Ganesh Pai; Amarender S Puri; Surinder S Rana; Gautam Ray; Shivaram P Singh; Ajit Sood
Journal:  Indian J Gastroenterol       Date:  2012-10-17

10.  Filtrated Adipose Tissue-Derived Mesenchymal Stem Cell Lysate Ameliorates Experimental Acute Colitis in Mice.

Authors:  Takahiro Nishikawa; Keiko Maeda; Masanao Nakamura; Takeshi Yamamura; Tsunaki Sawada; Yasuyuki Mizutani; Takanori Ito; Takuya Ishikawa; Kazuhiro Furukawa; Eizaburo Ohno; Ryoji Miyahara; Hiroki Kawashima; Takashi Honda; Masatoshi Ishigami; Tokunori Yamamoto; Seiji Matsumoto; Yuji Hotta; Mitsuhiro Fujishiro
Journal:  Dig Dis Sci       Date:  2020-06-01       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.